Bulletin
Investor Alert

Market Pulse Archives

Aug. 25, 2021, 7:15 a.m. EDT

Coronavirus tally: Daily average of COVID-19 cases rises to 7-month high, as J&J data supports booster shots

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

JNJ

The global tally for the coronavirus-borne illness climbed to 213.30 million as of early Wednesday, while the death toll rose to 4,454,812, according to data aggregated by Johns Hopkins University . The U.S. led the world with a total of 38.08 million cases and 630,838 deaths. The daily average of new cases over the past seven days rose to 151,441 as of Tuesday, up 28% from two weeks ago, and the highest count since Jan. 29, according to a New York Times tracker . The daily average for deaths increased to 1,116, up 84% in two weeks and the most since March 19. The daily average for hospitalizations of rose to 94,082, up 35% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated grew to 171.4 million, or 51.6% of the total U.S. population, according to data from the Centers for Disease Control and Prevention , while the number of people who have received at least one dose of a vaccine edged up to 202.04 million, or 60.9% of the total population. Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.23% announced Wednesday data that supported the use of a COVID-19 vaccine booster shot, eight months after people previously received J&J's single-shot vaccine.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 164.87
-0.38 -0.23%
Volume: 10.55M
Jan. 21, 2022 4:00p
P/E Ratio
24.64
Dividend Yield
2.57%
Market Cap
$434.04 billion
Rev. per Employee
$679,695
loading...

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.